VisionGate offers the earliest detection of lung cancer when the chance for a cure is the best.Our quick, non-intrusive test is based on 3D cellular imaging and AI.
The Cell-CT
At the Forefront of Novel Science
VisionGate is a biotechnology company leading the battle against lung cancer in high-risk patients using simple non-intrusive testing, 3D cell imaging, and a patented AI-powered cancer detection process.
VisionGate offers the earliest detections of lung cancer when the chance for a sure is the best. Our quick non-intrusive test is based on 3D cellular imaging and Ai.